{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:47:54Z","timestamp":1760028474354,"version":"build-2065373602"},"reference-count":45,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objective: In our study, we aimed to investigate the differences in metabolic parameters, serum asprosin and peptide tyrosine tyrosine (PYY) levels in a bipolar disorder manic (BD-M) group, a euthymic group and in healthy controls; we also aimed to evaluate the relationship of asprosin and PYY levels with metabolic parameters and psychopathology in patients. Methods: The study included 54 manic patients, 40 euthymic patients and 39 healthy controls. The sociodemographic characteristics of the participants were recorded, and biochemical parameters and asprosin and PYY levels were measured. The Young Mania Rating Scale (YMRS) and the Hamilton Depression Rating Scale (HAM-D) were completed. Results: Body mass index (BMI) showed significant differences between the three groups (p &lt; 0.001); the lowest was found in the control group and the highest in the euthymic group. Triglyceride levels were significantly higher in the euthymic group compared with the BD-M group and controls (p = 0.003). Glucose levels were significantly higher in the BD-M group compared with euthymic (pmanic-euthymic = 0.008) and controls (pmanic-control &lt; 0.001). Asprosin (pmanic-control &lt; 0.001, peuthymic-control = 0.046, pmanic-euthymic = 0.015) and PYY (pmanic-control &lt; 0.001, peuthymic-control = 0.037, pmanic-euthymic = 0.002) levels were significantly different between the three groups, with the lowest levels in the BD-M group and the highest levels in the control group. The eta squared = 0.18 for asprosin and 0.21 for PYY. In the BD-M group, a moderate negative correlation was found between YMRS and asprosin (r = \u22120.345; p = 0.011) and PYY (r = \u22120.376; p = 0.005) levels. ROC analysis results showed that asprosin and PYY could be used to predict the manic period in BD-I (AUCasprosin:0.775; AUCPYY:0.760). After adjusting for asprosin as a covariate using ANCOVA, the difference in PYY between groups remained significant (manic\u2013euthymic groups, p = 0.040; manic\u2013control groups, p = 0.013). Conclusions: The study results revealed that asprosin and PYY levels were low, and metabolic parameters were impaired in the patients. Low asprosin and PYY levels may be indicators of impaired energy homeostasis in BD-I. PYY may be a state marker for manic episodes.<\/jats:p>","DOI":"10.3390\/jcm14031012","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T10:09:52Z","timestamp":1738750192000},"page":"1012","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Asprosin and Peptide Tyrosine Tyrosine (PYY) Levels in Bipolar Disorder"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0224-8272","authenticated-orcid":false,"given":"Nilifer","family":"G\u00fcrb\u00fczer","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Erzurum Faculty of Medicine, University of Health Sciences, Erzurum 25240, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2300-2634","authenticated-orcid":false,"given":"Elif \u00d6zcan","family":"Tozo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Erzurum Faculty of Medicine, University of Health Sciences, Erzurum 25240, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2033-3692","authenticated-orcid":false,"given":"Alev Lazoglu","family":"Ozkaya","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Erzurum City Hospital, Erzurum 25240, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-1534","authenticated-orcid":false,"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar Disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"ref_2","unstructured":"Arlington, V. (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jad.2021.12.110","article-title":"Prevalence of Type 2 Diabetes Mellitus, Impaired Fasting Glucose, General Obesity, and Abdominal Obesity in Patients with Bipolar Disorder: A Systematic Review and Meta-Analysis","volume":"300","author":"Liu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jad.2015.06.006","article-title":"Glucose Metabolism Alterations in Patients with Bipolar Disorder","volume":"184","author":"Rosso","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2007.12.233","article-title":"Prevalence and Correlates of Overweight in Drug-Na\u00efve Patients with Bipolar Disorder","volume":"110","author":"Maina","year":"2008","journal-title":"J. Affect. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Misiak, B., Kowalski, K., Sta\u0144czykiewicz, B., Bartoli, F., Carr\u00e0, G., Samochowiec, J., Samochowiec, A., and Frydecka, D. (2022). Appetite-Regulating Hormones in Bipolar Disorder: A Systematic Review and Meta-Analysis. Front. Neuroendocrinol., 67.","DOI":"10.1016\/j.yfrne.2022.101013"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41380-023-01964-w","article-title":"Microbiota\u2013Gut\u2013Brain Axis Mechanisms in the Complex Network of Bipolar Disorders: Potential Clinical Implications and Translational Opportunities","volume":"28","author":"Ortega","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Maletic, V., and Raison, C. (2014). Integrated Neurobiology of Bipolar Disorder. Front. Psychiatry, 5.","DOI":"10.3389\/fpsyt.2014.00098"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neubiorev.2016.06.040","article-title":"Mitochondrial Dysfunction in Bipolar Disorder: Evidence, Pathophysiology and Translational Implications","volume":"68","author":"Scaini","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jad.2023.07.079","article-title":"Thiol-Disulphide Homeostasis, Ischemia-Modified Albumin, Complete Blood Count-Derived Inflammatory Markers and C-Reactive Protein from Acute Mania to Early Remission in Bipolar Disorder","volume":"339","author":"Korkmaz","year":"2023","journal-title":"J. Affect. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200721010-00001","article-title":"Mitochondrial Dysfunction as the Molecular Basis of Bipolar Disorder: Therapeutic Implications","volume":"21","author":"Kato","year":"2007","journal-title":"CNS Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.mp.4001711","article-title":"Mitochondrial Dysfunction in Bipolar Disorder: Evidence from Magnetic Resonance Spectroscopy Research","volume":"10","author":"Stork","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2017.05.033","article-title":"Endocannabinoid Modulation of Homeostatic and Non-Homeostatic Feeding Circuits","volume":"124","author":"Lau","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_14","first-page":"30","article-title":"The Potential Impact of Agouti Related Peptide and Asprosin on Metabolic Parameters and Eating Behavior in Attention Deficit Hyperactivity Disorder","volume":"61","author":"Zengil","year":"2024","journal-title":"Noropsikiyatri Ars."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Roman\u00ed-P\u00e9rez, M., Bullich-Vilarrubias, C., L\u00f3pez-Almela, I., Li\u00e9bana-Garc\u00eda, R., Olivares, M., and Sanz, Y. (2021). The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115830"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tem.2021.02.005","article-title":"Old Paradoxes and New Opportunities for Appetite Control in Obesity","volume":"32","author":"Magnan","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2147\/NDT.S111818","article-title":"Neurobiology of Hedonic Tone: The Relationship between Treatment-Resistant Depression, Attention-Deficit Hyperactivity Disorder, and Substance Abuse","volume":"12","author":"Sternat","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.psychres.2017.11.018","article-title":"Serum Agouti-Related Protein (AgRP) Levels in Bipolar Disorder: Could AgRP Be a State Marker for Mania?","volume":"260","author":"Parlak","year":"2018","journal-title":"Psychiatry Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.kjms.2018.04.003","article-title":"Metabolic Syndrome and Vaspin in Patients with Bipolar Disorder","volume":"34","author":"Ertekin","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpsychires.2011.11.010","article-title":"Increased Levels of Adipokines in Bipolar Disorder","volume":"46","author":"Barbosa","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yuan, M., Li, W., Zhu, Y., Yu, B., and Wu, J. (2020). Asprosin: A Novel Player in Metabolic Diseases. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00064"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1152\/ajpendo.00568.2007","article-title":"Peptide YY: Obesity\u2019s Cause and Cure?","volume":"293","author":"Ravussin","year":"2007","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pcn.12931","article-title":"Clinical Validity and Intrarater and Test\u2013Retest Reliability of the Structured Clinical Interview for DSM-5\u2014Clinician Version (SCID-5-CV)","volume":"73","author":"Loureiro","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_24","first-page":"51","article-title":"Adaptation and Reliability of the Structured Clinical Interview for DSM-5-Disorders\u2014Clinician Version (SCID-5\/CV) to the Turkish Language","volume":"1","author":"Elbir","year":"2019","journal-title":"Turk Psikiyatr. Derg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.119.264143","article-title":"New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology","volume":"372","author":"Michel","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chiva-blanch, G., and Badimon, L. (2020). Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies. Nutrients, 12.","DOI":"10.3390\/nu12010108"},{"key":"ref_27","first-page":"1505","article-title":"Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review","volume":"13","author":"Paredes","year":"2023","journal-title":"Eur. J. Investig. Health Psychol. Educ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ando.2023.03.006","article-title":"Metabolic Disorders Induced by Psychotropic Drugs","volume":"84","author":"Scheen","year":"2023","journal-title":"Ann. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A Rating Scale for Mania","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"ref_30","first-page":"107","article-title":"Young Mani Derecelendirme Ol\u00e7e\u011finin T\u00fcrkiye\u2019de Ge\u00e7erlik ve G\u00fcvenilirli\u011fi [Reliability and Validity of Turkish Translation of Young Mania Rating Scale","volume":"2","author":"Oral","year":"2002","journal-title":"Turk Psikiyatr. Derg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A Rating Scale for Depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A Structured Interview Guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_33","first-page":"251","article-title":"Hamilton Depresyon Derecelendirme \u00d6l\u00e7e\u011fi (HDD\u00d6)\u2019nin Ge\u00e7erlili\u011fi-G\u00fcvenirlili\u011fi ve Klinikte Kullan\u0131m\u0131","volume":"4","author":"Akdemir","year":"1996","journal-title":"Psikiyatr. Psikol. Psikofarmakol. Derg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nm.4432","article-title":"Asprosin Is a Centrally Acting Orexigenic Hormone","volume":"23","author":"Duerrschmid","year":"2017","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpsychires.2006.01.011","article-title":"Long-Term Antipsychotic Treatments and Crossover Studies in Rats: Differential Effects of Typical and Atypical Agents on the Expression of Antioxidant Enzymes and Membrane Lipid Peroxidation in Rat Brain","volume":"41","author":"Pillai","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pbb.2012.09.010","article-title":"Lithium and Valproate Modulate Energy Metabolism in an Animal Model of Mania Induced by Methamphetamine","volume":"103","author":"Feier","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.neuroimage.2011.12.023","article-title":"Postprandial Plasma PYY Concentrations Are Associated with Increased Regional Gray Matter Volume and RCBF Declines in Caudate Nuclei--a Combined MRI and H2(15)O PET Study","volume":"1","author":"Weise","year":"2012","journal-title":"Neuroimage"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Dai, W., Liu, J., Qiu, Y., Teng, Z., Li, S., Yuan, H., Huang, J., Xiang, H., Tang, H., and Wang, B. (2022). Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.893567"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-3956(88)90030-1","article-title":"Neuropeptide Y and Peptide YY as Possible Cerebrospinal Fluid Markers for Major Depression and Schizophrenia, Respectively","volume":"22","author":"Wahlestedt","year":"1988","journal-title":"J. Psychiatr. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1523\/JNEUROSCI.1008-05.2005","article-title":"Mechanisms of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Inhibition of Identified Green Fluorescent Protein-Expressing GABA Neurons in the Hypothalamic Neuroendocrine Arcuate Nucleus","volume":"25","author":"Tamamaki","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jad.2017.07.052","article-title":"Relationship of Executive Functioning Deficits to N-Acetyl Aspartate (NAA) and Gamma-Aminobutyric Acid (GABA) in Youth with Bipolar Disorder","volume":"225","author":"Huber","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpsychires.2021.03.013","article-title":"Peripheral Metabolic State and Immune System in First-Episode Psychosis\u2014A Gene Expression Study with a Prospective One-Year Follow-Up","volume":"137","author":"Linnaranta","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-Chain Fatty Acids Stimulate Glucagon-like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/en.2014-1675","article-title":"Expression and Distribution of Glucagon-like Peptide-1 Receptor Mrna, Protein and Binding in the Male Nonhuman Primate (Macaca Mulatta) Brain","volume":"156","author":"Heppner","year":"2015","journal-title":"Endocrinology"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Chaves Filho, A.J.M., Cunha, N.L., de Souza, A.G., Soares, M.V.R., Juc\u00e1, P.M., de Queiroz, T., Oliveira, J.V.S., Valvassori, S.S., Barichello, T., and Quevedo, J. (2020). The GLP-1 Receptor Agonist Liraglutide Reverses Mania-like Alterations and Memory Deficits Induced by D-Amphetamine and Augments Lithium Effects in Mice: Relevance for Bipolar Disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 99.","DOI":"10.1016\/j.pnpbp.2020.109872"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/1012\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:23Z","timestamp":1760027243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/1012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14031012"],"URL":"https:\/\/doi.org\/10.3390\/jcm14031012","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}